Replies to post #170655 on Avid Bioservices Inc (CDMO)

[pphmtoolong]

S_S_R, not surprising that you rise to EBS defense. You seem to share his opinions.

Opinions that focus on suspicions about management motives and past actions of board members can be perceived as designed to distract from analysis of current Peregrine activities. No real harm in this, but no reason that others should not point out the patterns.

GLTA, Paul

[Protector]

ssr, with one little important thing you forgot.

Eyebuy’s perspective is just as valid as the next posters….and he/she doesn't have to write an epistle to make their point…..

PPHM related opinion, yes, you are correct for 100%.

Wrong PPHM or Market or Lawsuit related facts, wrong information, techniques, etc...100% noop (EBS now has several times described wrong mechanisms or launches wrong assumptions as fact on the board. See Bunglers last mail about FACTS when incorporated into a lawsuit or my posts about the PPHMP shares.

And those you can most of the time not address in one liners if you want the PPHM investor that reads the board to understand, knowing some of them may be new and not have the PPHM history.

But what does certainly not fit your assessment are personal or style remarks such as the to many "!", to long posts, CP part of a trader team, and other blank accusations. That is why some posters react and have the sentiment EBS tries to either discredit me or at least has a serious problem with my posting, issue for which IHub has a solution called the IGNORE button.

You may have noticed that I posted long long positive since the beginning I post here, because I am PPHM long. Enthusiastic, yes, sure, undeniably, but I provide either prove, sources or detailed reasoning and write (SPECULATION) in my posts - and that is a verifiable fact by all.

But unlike EBS I never changed sides, because even if a family member dies - which I regret and I can understand the bitterness if Bavituximab could have been a possible solution if it was on the market - then I would still not turn against PPHM and on top of it shoot my own investment down if I am long. Now, I am not EBS and maybe he needs to do that to get over it, I will not judge that, it is personal for everyone.

But NOW at this point it should be clear to EBS, since the lawsuit filing, that PPHM was really and without the slightest doubt a VICTIM in the dose switching and that MANAGEMENT did a great job, not only in salvaging but also in navigating the waters under financial stress, pending reputation loss and increase shareholders pressure.

While EVERYONE can see that, and it can be made hard with facts (2xPIII FDA design approval, Fast Track, about 80Milj on the bank, owning pipelines 100% unencumbered, no creditors, 100% contractual control of IP related to PS-binding, no going concern, Avid profits, etc), it doesn't seem to fit others. Trying to understand why that could be.

I am sometimes under the impression (IMPRESSION) that there are a cluster of people that have a personal issue with Management/BoD and that whatever management does it will never be good. I am a management supporter.

[biopharm]

Why is it that every time I see articles about immunotherapy cancer drugs, PPHM is almost never mentioned? This platform is way too far along human trials to be not included in the mainstream conversation.

That was a clip from a post back in March of 2014

It looks like you underestimated before and you'll continue to underestimate the featherweight in the ring with Big Pharma.

Memorial Sloan Kettering and Astrazeneca = mainstream, though there is more to come... dozens more as SK has told us but I'm sure they will not tip their cards and show what is coming

Well... it looks like BTD's are coming but what else : )